Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. Ca A Cancer J Clinicians. 2020;70(3):145–164. doi:10.3322/caac.21601
   PubMed Web of Science ®Google Scholar
• Araghi M, Arnold M, Rutherford MJ, et al. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 2021;70(1):114–126. doi:10.1136/gutjnl-2020-320625
   PubMed Web of Science ®Google Scholar
• Yoshino T, Argilés G, Oki E, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer. Ann Oncol. 2021;32(12):1496–1510. doi:10.1016/j.annonc.2021.08.1752
   PubMed Web of Science ®Google Scholar
• Pastille E, Frede A, McSorley HJ, et al. Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog. 2017;13(9):e1006649. doi:10.1371/journal.ppat.1006649
   PubMed Web of Science ®Google Scholar
• Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019;125(23):4139–4147. doi:10.1002/cncr.32163
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51. doi:10.1016/j.cell.2018.03.006
   PubMed Web of Science ®Google Scholar
• Gao G, Guo X, Gu W, Lu Y, Chen Z. miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer. Aging (Albany NY). 2022;14(8):3387–3399. doi:10.18632/aging.203998
   PubMedGoogle Scholar
• Wang Y, Hu S, Zhang H, et al. MiRNA-186-5p exerts an anticancer role in breast cancer by downregulating CXCL13. J Healthc Eng. 2022;2022:4891889. doi:10.1155/2022/4891889
   PubMed Web of Science ®Google Scholar
• Yang X, Liu R. Long non-coding RNA HCG18 promotes gastric cancer progression by regulating miRNA-146a-5p/tumor necrosis factor receptor-associated factor 6 axis. Bioengineered. 2022;13(3):6781–6793. doi:10.1080/21655979.2022.2034565
   PubMed Web of Science ®Google Scholar
• Yu Z, Liu Y, Li Y, et al. miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L. Brain Res Bull. 2022;179:1–12. doi:10.1016/j.brainresbull.2021.11.016
   PubMed Web of Science ®Google Scholar
• Segal M, Slack FJ. Challenges identifying efficacious miRNA therapeutics for cancer. Expert Opin Drug Discov. 2020;15(9):987–992. doi:10.1080/17460441.2020.1765770
   PubMed Web of Science ®Google Scholar
• Koo KH, Kwon H. MicroRNA miR-4779 suppresses tumor growth by inducing apoptosis and cell cycle arrest through direct targeting of PAK2 and CCND3. Cell Death Dis. 2018;9(2):77. doi:10.1038/s41419-017-0100-x
   PubMedGoogle Scholar
• Li Y, Xun J, Wang B, et al. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer. J Transl Med. 2021;19(1):429. doi:10.1186/s12967-021-03102-y
   PubMed Web of Science ®Google Scholar
• Li C, Ding D, Gao Y, Li Y. MicroRNA‑3651 promotes colorectal cancer cell proliferation through directly repressing T‑box transcription factor 1. Int J Mol Med. 2020;45(3):956–966. doi:10.3892/ijmm.2020.4458
   PubMed Web of Science ®Google Scholar
• Cekaite L, Eide PW, Lind GE, Skotheim RI, Lothe RA. MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget. 2016;7(6):6476–6505. doi:10.18632/oncotarget.6390
   PubMedGoogle Scholar
• Wu H, Wu H, Sun P, Zhu D, Ma M, Fan W. miR-155-5p promotes cell proliferation and migration of clear cell renal cell carcinoma by targeting PEG3. Urol Int. 2021;105(9–10):906–915. doi:10.1159/000514416
   PubMed Web of Science ®Google Scholar
• Li D, Hao X, Song Y. Identification of the key MicroRNAs and the miRNA-mRNA regulatory pathways in prostate cancer by bioinformatics methods. Biomed Res Int. 2018;2018:6204128. doi:10.1155/2018/6204128
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991–5. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846–1847. doi:10.1093/bioinformatics/btm254
   PubMed Web of Science ®Google Scholar
• Chen Z, Ren R, Wan D, et al. Hsa_circ_101555 functions as a competing endogenous RNA of miR-597-5p to promote colorectal cancer progression. Oncogene. 2019;38(32):6017–6034. doi:10.1038/s41388-019-0857-8
   PubMed Web of Science ®Google Scholar
• Wettenhall JM, Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004;20(18):3705–3706. doi:10.1093/bioinformatics/bth449
   PubMed Web of Science ®Google Scholar
• Chen H, Boutros PC. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinf. 2011;12:35. doi:10.1186/1471-2105-12-35
   PubMed Web of Science ®Google Scholar
• Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One. 2018;13(10):e0206239. doi:10.1371/journal.pone.0206239
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. doi:10.7554/eLife.05005
   Web of Science ®Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–d131. doi:10.1093/nar/gkz757
   PubMed Web of Science ®Google Scholar
• Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141. doi:10.1016/j.xinn.2021.100141
   PubMedGoogle Scholar
• Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431–432. doi:10.1093/bioinformatics/btq675
   PubMed Web of Science ®Google Scholar
• Tomczak K, Czerwińska P, Wiznerowicz M. The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1a):A68–77. doi:10.5114/wo.2014.47136
   PubMedGoogle Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259. doi:10.1007/978-1-4939-7493-1_12
   PubMedGoogle Scholar
• Wickham H. ggplot2. Wiley Interdiscip Rev. 2011;3(2):180–185. doi:10.1002/wics.147
   Google Scholar
• Chakrabarti S, Peterson CY, Sriram D, Mahipal A. Early stage colon cancer: current treatment standards, evolving paradigms, and future directions. World J Gastrointest Oncol. 2020;12(8):808–832. doi:10.4251/wjgo.v12.i8.808
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89–103. doi:10.5114/pg.2018.81072
   PubMed Web of Science ®Google Scholar
• Littlejohns P, Tamber S, Ranson P, Campbell B. Treatment for liver metastases from colorectal cancer. Lancet Oncol. 2005;6(2):73. doi:10.1016/s1470-2045(05)01729-8
   PubMed Web of Science ®Google Scholar
• Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016;22(30):6876–6889. doi:10.3748/wjg.v22.i30.6876
   PubMed Web of Science ®Google Scholar
• Kadkhoda S, Ghafouri-Fard S. The importance of miRNA-630 in human diseases with an especial focus on cancers. Cancer Cell Int. 2022;22(1):105. doi:10.1186/s12935-022-02531-z
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang L, Chen X. Updated review of advances in microRNAs and complex diseases: experimental results, databases, webservers and data fusion. Brief Bioinform. 2022;23(6). doi:10.1093/bib/bbac397
   Web of Science ®Google Scholar
• Lin J, Chen X, Sun M, et al. Upregulation of microRNA-181a-5p increases the sensitivity of HS578T breast cancer cells to cisplatin by inducing vitamin D receptor-mediated cell autophagy. Oncol Lett. 2021;21(4):247. doi:10.3892/ol.2021.12508
   PubMed Web of Science ®Google Scholar
• Zhou D, Bai J, Hu Y, et al. miR-93-5p promotes invasion and migration of triple negative breast cancer cells by targeting FGD5. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36(9):794–801.
   PubMedGoogle Scholar
• Li C, Zheng X, Li W, Bai F, Lyu J, Meng QH. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms. BMC Cancer. 2018;18(1):61. doi:10.1186/s12885-017-3753-z
   PubMed Web of Science ®Google Scholar
• Noorolyai S, Shajari N, Baghbani E, Sadreddini S, Baradaran B. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128. doi:10.1016/j.gene.2019.02.076
   PubMed Web of Science ®Google Scholar
• Yang F, Gao JY, Chen H, Du ZH, Zhang XQ, Gao W. Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer. Onco Targets Ther. 2017;10:4413–4422. doi:10.2147/ott.S145601
   PubMed Web of Science ®Google Scholar
• Jin Y, Chen W, Yang H, et al. Scutellaria barbata D. Don inhibits migration and invasion of colorectal cancer cells via suppression of PI3K/AKT and TGF-β/Smad signaling pathways. Exp Ther Med. 2017;14(6):5527–5534. doi:10.3892/etm.2017.5242
   PubMed Web of Science ®Google Scholar
• Tréhoux S, Lahdaoui F, Delpu Y, et al. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta. 2015;1853(10 Pt A):2392–2403. doi:10.1016/j.bbamcr.2015.05.033
   PubMed Web of Science ®Google Scholar
• Cui LH, Xu HR, Yang W, Yu LJ. lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p. Onco Targets Ther. 2018;11:7715–7724. doi:10.2147/ott.S178597
   PubMed Web of Science ®Google Scholar
• Qin L, Sun X, Zhou F, Liu C. CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1. World J Surg Oncol. 2021;19(1):184. doi:10.1186/s12957-021-02287-2
   PubMed Web of Science ®Google Scholar
• Karimi L, Jaberi M, Asadi M, et al. Significance of microRNA-330-5p/TYMS expression axis in the pathogenesis of colorectal tumorigenesis. J Gastrointest Cancer. 2022;53(4):965–970. doi:10.1007/s12029-021-00695-x
   PubMed Web of Science ®Google Scholar
• Deng J, Liu S, Zhao L, et al. SND1 acts as a functional target of miR-330-5p involved in modulating the proliferation, apoptosis and invasion of colorectal cancer cells. Biochem Biophys Res Commun. 2022;615:116–122. doi:10.1016/j.bbrc.2022.05.045
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang F, Zhang L, et al. LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer. Cancer Med. 2020;9(4):1515–1528. doi:10.1002/cam4.2815
   PubMed Web of Science ®Google Scholar
• Jing QB, Tong HX, Tang WJ, Tian SD. Clinical significance and potential regulatory mechanisms of serum response factor in 1118 cases of thyroid cancer based on gene chip and RNA-sequencing data. Med Sci Monit. 2020;26:e919302. doi:10.12659/msm.919302
   PubMed Web of Science ®Google Scholar
• Yi M, Li M, Long X, et al. miR-520e regulates cell proliferation, apoptosis and migration in breast cancer. Oncol Lett. 2016;12(5):3543–3548. doi:10.3892/ol.2016.5085
   PubMed Web of Science ®Google Scholar
• Tian JH, Liu WD, Zhang ZY, et al. Influence of miR-520e-mediated MAPK signalling pathway on HBV replication and regulation of hepatocellular carcinoma cells via targeting EphA2. J Viral Hepat. 2019;26(4):496–505. doi:10.1111/jvh.13048
   PubMed Web of Science ®Google Scholar
• Dong S, Xue S, Sun Y, et al. MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1. J Investig Med. 2021;69(1):66–74. doi:10.1136/jim-2020-001562
   PubMed Web of Science ®Google Scholar
• Guo Q, Dong L, Zhang C, Liu D, Peng P. MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer. Bioengineered. 2022;13(3):5357–5372. doi:10.1080/21655979.2021.2018972
   PubMed Web of Science ®Google Scholar
• Song B, Yan J, Liu C, Zhou H, Zheng Y. Tumor suppressor role of miR-363-3p in gastric cancer. Med Sci Monit. 2015;21:4074–4080. doi:10.12659/msm.896556
   PubMed Web of Science ®Google Scholar
• Dong J, Geng J, Tan W. MiR-363-3p suppresses tumor growth and metastasis of colorectal cancer via targeting SphK2. Biomed Pharmacother. 2018;105:922–931. doi:10.1016/j.biopha.2018.06.052
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27. doi:10.1016/j.neo.2022.01.001
   PubMed Web of Science ®Google Scholar
• Plotnikova O, Baranova A, Skoblov M. Comprehensive analysis of human microRNA-mRNA interactome. Front Genet. 2019;10:933. doi:10.3389/fgene.2019.00933
   PubMed Web of Science ®Google Scholar
• Lan J, Sun L, Xu F, et al. M2 macrophage-derived exosomes promote cell migration and invasion in colon cancer. Cancer Res. 2019;79(1):146–158. doi:10.1158/0008-5472.Can-18-0014
   PubMed Web of Science ®Google Scholar
• Gao L, Zhou Y, Zhou SX, et al. PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells. Oncol Rep. 2017;37(1):408–416. doi:10.3892/or.2016.5216
   PubMed Web of Science ®Google Scholar
• Kipkeeva F, Muzaffarova T, Korotaeva A, et al. The features of immune checkpoint gene regulation by microRNA in cancer. Int J Mol Sci. 2022;23(16):9324. doi:10.3390/ijms23169324
   PubMed Web of Science ®Google Scholar
• Wang Q, Lin W, Tang X, et al. The roles of microRNAs in regulating the expression of PD-1/PD-L1 immune checkpoint. Int J Mol Sci. 2017;18(12):2540. doi:10.3390/ijms18122540
   PubMed Web of Science ®Google Scholar
• Skafi N, Fayyad-Kazan M, Badran B. Immunomodulatory role for MicroRNAs: regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression. Gene. 2020;754:144888. doi:10.1016/j.gene.2020.144888
   PubMed Web of Science ®Google Scholar